SHOCKING: 12 - What They Never Told You

Former DeepMind Officials Get Together To Develop AI For Stock and Crypto Picking

Martin Schmid, Rudolf Kadlec, and Matej Moravcik left Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL)-owned DeepMind in January to set up EquiLibre Technologies, CNBC reports. The trio seek to develop artificial intelligence for stock and crypto picking. They look to use reinforcement learning to train an AI system to buy and sell shares and make a…

Benzinga · Apr 5, 2022

Here's Why Mizuho Views Uber As Top Pick

Mizuho analyst James Lee kept a Buy rating on Uber Technologies Inc (NYSE:UBER) with a $72 price target (100% upside). Lee reiterated Uber as a top pick in the U.S. Washington passed a new law that enabled gig drivers to remain as contractors while receiving benefits like injury protection and paid medical leave.  The law…

Benzinga · Apr 4, 2022

Read About Apple's Latest Subscription Offering As It Looks To Reduce Dependence On Devices

Apple Inc (NASDAQ:AAPL) launched Apple Business Essentials, a new program for businesses to set up, manage and install software on workers' iPhones, iPads, and Macs. The product is aimed at smaller customers, primarily those without dedicated IT departments. It comes at a monthly price of $2.99 to $24.99 per worker. The product enables…

Benzinga · Apr 1, 2022

Why BioNTech Shares Are Surging Today

BioNTech SE (NASDAQ:BNTX) reported Q4 FY21 revenues of €5.53 billion compared to €345.4 million a year ago, mainly due to high demand for the company's COVID-19 vaccine. BioNTech and its partner Pfizer Inc (NYSE:PFE) delivered approximately 2.6 billion doses of Comirnaty/BNT162b2 worldwide in 2021, including over 1 billion doses to low- and middle-income countries. As…

Benzinga · Mar 30, 2022

Sanctions On Russia After Ukraine Invasion, Are Likely To Lead To Higher Prices: CNBC

According to an energy expert, consumers will have to be ready for higher prices as Russia continues its war in Ukraine and disruptions to the global energy market persist, writes CNBC. Washington and its allies have imposed sanctions on Russia, including energy exports, which could lead to inflation. “What is the…

Benzinga · Mar 29, 2022

US Goods Risk Delay As China's Lockdowns Heightens Shipping Port Jams: Bloomberg

The key Chinese ports of Shenzhen and Hong Kong face congestion, which rose to the highest level in five months due to COVID-19 lockdowns. It could pose possible delays to goods heading to the U.S. this summer, reported Bloomberg. Ryan Closser, a director at FourKites, states, “Shenzhen is the second-busiest port…

Benzinga · Mar 24, 2022

More Trouble Looms For Evergrande As Angry Debtors Prepare To Take Legal Action: FT

A group of distressed debt investors in the U.S. and U.K. are prepared to take action against Evergrande Group (OTC:EVGPY), the Financial Times reports. The investors included Saba Capital, Redwood Capital Management, and Ashmore. The action came after the indebted property developer admitted that undisclosed lenders took $2.1 billion in cash from its…

Benzinga · Mar 23, 2022

US, UK Announce Trade Accord To Remove Tariffs On British Steel, American Whiskey: WSJ

The U.S. and U.K. have announced a trade deal to remove tariffs on British steel & aluminum and American whiskey, motorcycles, and tobacco, the Wall Street Journal reported. Biden administration officials said the agreement would allow the U.K to ship “historically-based sustainable volumes” of steel and aluminum products to the U.S. without…

Benzinga · Mar 23, 2022

US DOJ Accuses Google Of Misusing Legal Privilege To Hide Sensitive Emails: WSJ

The U.S. Justice Department alleged Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google improperly invoked the legal privilege to shield sensitive internal communications for years, the Wall Street Journal reports from U.S. district court filing. The DOJ wanted Google to turn over internal emails that it had withheld or censored in the antitrust case filed against it by state…

Benzinga · Mar 22, 2022

WHO Conditionally Recommends Merck's COVID-19 Antiviral Pill For High-Risk Patients

A World Health Organization (WHO) panel has backed the use of Merck & Co Inc's (NYSE:MRK) COVID-19 antiviral pill for high-risk patients. The expert panel conditionally recommended molnupiravir for patients with non-severe disease at high risk of hospitalization, such as the immunocompromised, the unvaccinated, older people, and those with chronic conditions. The recommendation was…

Benzinga · Mar 3, 2022